Can thyroid underfunction, metabolic dysregulation, adrenal steroid underoutput, and nutrient insufficiency reduce testosterone and androgen availability?

The̲s̲i̲s̲ ̲s̲t̲a̲t̲e̲m̲e̲m̲t̲ ̲u̲p̲h̲e̲l̲d̲:̲ ̲Y̲e̲s̲,̲ ̲t̲h̲e̲ ̲s̲t̲a̲t̲e̲m̲e̲n̲t̲ ̲i̲s̲ ̲a̲c̲c̲u̲r̲a̲t̲e̲.̲ ̲M̲u̲l̲t̲i̲p̲l̲e̲ ̲e̲n̲d̲o̲c̲r̲i̲n̲e̲ ̲p̲a̲t̲h̲w̲a̲y̲s̲ ̲a̲n̲d̲ ̲m̲e̲t̲a̲b̲o̲l̲i̲c̲ ̲f̲a̲c̲t̲o̲r̲s̲ ̲w̲o̲r̲k̲ ̲i̲n̲ ̲t̲a̲n̲d̲e̲m̲t̲o̲ ̲r̲e̲g̲u̲l̲a̲t̲e̲ ̲s̲y̲s̲t̲e̲m̲i̲c̲ ̲t̲e̲s̲t̲o̲s̲t̲e̲r̲o̲n̲e̲ ̲p̲r̲o̲d̲u̲c̲t̲i̲o̲n̲ ̲a̲n̲d̲ ̲t̲i̲s̲s̲u̲e̲-̲s̲p̲e̲c̲i̲f̲i̲c̲ ̲a̲n̲d̲r̲o̲g̲e̲n̲ ̲a̲v̲a̲i̲l̲a̲b̲i̲l̲i̲t̲y̲.̲

Clinical Evidence

• Thyroid Function: Clinical studies and Mendelian randomization analyses establish a direct link between thyroid activity and testosterone. Hypothyroidism or low triiodothyronine (T3) levels systematically reduce total testosterone, which typically normalizes after thyroid hormone replacement therapy.
• Metabolic Dysregulation: Metabolic syndrome, obesity, and insulin resistance are strongly associated with a decline in testosterone. Men with insulin resistance show a blunted testicular response to gonadotropic stimulation, leading to functional hypogonadotropic hypogonadism.
• Adrenal Function: Adrenal output, specifically of dehydroepiandrosterone (DHEA) and its sulfate (DHEA-S), declines with age. This decline directly correlates with reduced local androgen levels in peripheral tissues, which rely on these precursors.
• Nutrient Status: Deficiencies in essential micronutrients (particularly zinc, vitamin D, and magnesium) are clinically linked to lower serum testosterone levels. Correcting these deficiencies has been shown to support healthy testosterone production.

Mechanistic Explanations

• Thyroid-Testicular Axis: Low T3 impairs Leydig cell function by downregulating luteinizing hormone (LH) receptors and the steroidogenic acute regulatory (StAR) protein, which is necessary for mitochondrial cholesterol transport. Additionally, thyroid hormone deficiency reduces the hepatic synthesis of sex hormone-binding globulin (SHBG) via the transcription factor HNF-4alpha, which alters the balance of free, bioavailable testosterone in circulation.
• Metabolic Signaling and Aromatization: Insulin resistance impairs insulin receptor-IRS1-AKT signaling in Leydig cells, inducing DAX-1 to suppress steroidogenic enzymes. Visceral adiposity upregulates the aromatase enzyme (CYP19A1), converting testosterone to estradiol, which exerts negative feedback on the hypothalamus and pituitary (suppressing HPT axis pulsatility). Inflammatory cytokines (TNF-alpha, IL-6) further impair Leydig cell function and promote oxidative stress.
• Adrenal Intracrinology: In older men, peripheral tissues (muscle, bone, adipose, and skin) convert circulating DHEA-S and DHEA into active testosterone and dihydrotestosterone (DHT) locally via intracrine enzymes. This process accounts for 40% to 50% of the total active androgen pool. A decline in adrenal precursors directly reduces this localized androgen source, independent of testicular output.
• Nutritional Co-Factors: Zinc is required for zinc-finger transcription factors that regulate the expression of StAR and CYP11A1 (cholesterol side-chain cleavage enzyme). Magnesium deficiency impairs 3-beta-HSD and 17-beta-HSD activity, halting the conversion of precursors into active testosterone.

Bottom line

Thyroid underfunction, metabolic dysregulation, adrenal precursor depletion (DHEA/DHEA-S), and key nutrient deficiencies (such as zinc and magnesium) collectively disrupt the hypothalamic-pituitary-gonadal axis, impair Leydig cell steroidogenesis, alter SHBG-bound transport, and starve peripheral tissues of the precursors needed for local androgen synthesis.